Cost Conscious

With sequestration-driven budget cuts and waning bipartisan support, the environment for medical research funding in the US is looking bleak and could turn bleaker still unless researchers work to turn things around, the University of Pennsylvania's Ezekiel Emanuel writes in a commentary published this week in the Journal of the American Medical Association. (Emanuel is the brother of Rahm Emanuel, the Chicago mayor and former chief of staff for President Barack Obama.)

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Related Posts

An Antibiotics Prize?

The Cost Burden

And the Result Is…

Put It in the Jar

In PNAS this week: transcript patterns in drug-resistant cancer cells, function of high-altitude adaption gene, and more.

Monitoring gene expression changes could help sniff out athletes using performance-enhancing drugs, New Scientist says.

The University of Southern California lodges a cross-complaint in its legal dispute with the University of California, San Diego, over a large Alzheimer's disease project.

Bioethicists weigh the idea of charging patients to take part in clinical research, coming down against the approach.